1Department of Neurosurgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
2Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, Michigan.
J Neurosurg. 2023 Aug 4;140(3):627-638. doi: 10.3171/2023.5.JNS2355. Print 2024 Mar 1.
Ventriculoperitoneal shunting, the most common treatment for the neurological disorder hydrocephalus, has a failure rate of up to 98% within 10 years of placement, mainly because of proximal obstruction of the ventricular catheter (VC). The authors developed a new VC design modified with tethered liquid perfluorocarbon (TLP) and tested it in a porcine model of hydrocephalus. In this study, they aimed to determine if their TLP VC design reduced cell surface attachment and consequent shunt obstruction in the pig model.
TLP VCs were designed to reduce drainage hole obstruction using modified TLP and slightly enlarged draining holes, but their number and placement remained very similar to standard VCs. First, the authors tested the device in nonhydrocephalic rats to assess biocompatibility. After confirming safety, they implanted the VCs in hydrocephalic pigs. Hydrocephalus was induced by intracisternal kaolin injections in 30-day-old domestic juvenile pigs. Surgical implantation of the ventriculoperitoneal shunt (clinical control or TLP) was performed 10-14 days postinduction and maintained up to 30 days posttreatment. MRI was performed to measure ventricular volume before treatment and 10 and 30 days after treatment. Histological and immunohistochemical analyses of brain tissue and explanted VCs, intracranial pressure measurement, and clinical scoring were performed when the animals were euthanized.
TLP VCs showed a similar surgical feel, kink resistance, and stiffness to control VCs. In rats (biocompatibility assessment), TLP VCs did not show brain inflammatory reactions after 30 or 60 days of implantation. In pigs, TLP VCs demonstrated increased survival time, improved clinical outcome scores, and significantly reduced total attached cells on the VCs compared with standard clinical control VCs. TLP VCs exhibited similar, but not worse, results related to ventriculomegaly, intracranial pressure, and the local tissue response around the cortical shunt track in pigs.
TLP VCs may be a strong candidate to reduce proximal VC obstruction and improve hydrocephalus treatment.
脑室-腹腔分流术是治疗神经疾病脑积水最常用的方法,但在放置后 10 年内,其失败率高达 98%,主要原因是脑室导管(VC)近端阻塞。作者开发了一种新型 VC 设计,对其进行了带有束缚液体全氟碳(TLP)的改良,并在猪脑积水模型中进行了测试。在这项研究中,他们旨在确定他们的 TLP VC 设计是否减少了猪模型中的细胞表面附着和随后的分流阻塞。
TLP VC 的设计旨在通过改良的 TLP 和稍微增大的引流孔来减少引流孔阻塞,但它们的数量和位置与标准 VC 非常相似。首先,作者在非脑积水大鼠中测试了该设备的生物相容性。在确认安全性后,他们将 VC 植入脑积水猪中。在 30 天大的家猪幼仔中通过脑室内高岭土注射诱导脑积水。在诱导后 10-14 天进行脑室-腹腔分流术(临床对照或 TLP)的外科植入,并在治疗后 30 天内维持。在治疗前、治疗后 10 天和 30 天进行 MRI 测量脑室容积。在动物安乐死时进行脑组织和取出的 VC 的组织学和免疫组织化学分析、颅内压测量和临床评分。
TLP VC 与对照 VC 具有相似的手术感觉、抗扭结性和刚性。在大鼠(生物相容性评估)中,TLP VC 在植入后 30 天或 60 天没有显示出脑炎症反应。在猪中,与标准临床对照 VC 相比,TLP VC 表现出延长的存活时间、改善的临床结局评分以及 VC 上附着的总细胞数量显著减少。TLP VC 在猪中表现出类似但不更差的结果,与脑室扩大、颅内压以及皮质分流轨道周围的局部组织反应有关。
TLP VC 可能是减少近端 VC 阻塞并改善脑积水治疗的有力候选物。